Teprotumumab reduces the proliferation and viability of pterygium fibroblasts. Richard S, Obied B, Abu-Dbai J, Massalha J, et al. Exp Eye Res 2025;260:110589.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Richard S, Obied B, Abu-Dbai J, Massalha J, et al. Teprotumumab reduces the proliferation and viability of pterygium fibroblasts. Exp Eye Res 2025;260:110589.
PMID: 40846246